Skip to main content
Adrienne Mishkin, MD, Psychiatry, New York, NY

Adrienne D Mishkin MD

Psychosomatic Medicine


Physician

Request Appointment
  • 622 W 168th StPh 16New York, NY 10032

  • Book by Phone+1(220) 215-9065

  • Fax+1 212-342-1699

Overview of  Dr. Mishkin

Adrienne Mishkin, MD, is a psychiatrist based in New York, NY, with a subspecialty in psychosomatic medicine. She completed her medical education (MD) and MPH degree at Tulane University School of Medicine in 2009, followed by a residency in psychiatry at St. Luke's-Roosevelt Hospital Center, now known as the Icahn School of Medicine West Campus, and a fellowship in consultation-liaison psychiatry at Montefiore Medical Center. Additionally, she earned a Master's in Bioethics from Einstein-Cardozo Bioethics Program. Her research and publications focus on psychiatric care in complex medical cases, stem cell transplant, sickle cell disease, telepsychiatry, access to care and medical ethics.

Education & Training

  • Einstein-Cardozo Bioethics Program (Yeshiva University)
    Einstein-Cardozo Bioethics Program (Yeshiva University)MS, Bioethics, 2013 - 2020
  • Montefiore Medical Center/Albert Einstein College of Medicine
    Montefiore Medical Center/Albert Einstein College of MedicineFellowship, Consultation-Liaison Psychiatry, 2013 - 2014
  • Icahn School of Medicine at Mount Sinai/Morningside/West
    Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Psychiatry, 2009 - 2013
  • Tulane Univ School of Public Health and Tropical Medicine
    Tulane Univ School of Public Health and Tropical MedicineMPH, Health Systems, 2005 - 2009
  • Tulane University School of Medicine
    Tulane University School of MedicineClass of 2009

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2010 - 2028
  • Psychiatry
    American Board of Psychiatry and Neurology Psychiatry
  • Psychosomatic Medicine
    American Board of Psychiatry and Neurology Psychosomatic Medicine

Publications & Presentations

PubMed

Press Mentions

  • New Gene Therapies Confront Many Sickle Cell Patients with an Impossible Choice: A Cure or Fertility
    New Gene Therapies Confront Many Sickle Cell Patients with an Impossible Choice: A Cure or FertilityDecember 8th, 2023

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: